General · 9 June 2026

GSK's $10.6B purchase pulls FTSE 100 down

Investors saw London’s main share index slip as GSK shares fell after announcing a major purchase. On Tuesday, the drugmaker said it plans to buy U.S. cancer drug developer Nuvalent for $10.6 billion, while the FTSE 100 dropped 0.3% and the FTSE 250 added 0.2%. By 0810 GMT, the benchmark stood at 10,341 points and GSK stock was down 2.8%.

By BriefTea Editorial · 9 June 2026 at 12:55

Reported by Reuters · How we write briefs

Get the app

More briefs

GeneralGoogle paying £260m to settle UK Play Store developer lawsuit PoliticsJames Cleverly steps down from the shadow cabinet to campaign for London mayor GeneralThe UK Navy just followed four Russian ships again GeneralSarah Ferguson is moving back to the UK following the Epstein scandal GeneralIcelanders vote on restarting EU membership talks after 13 years GeneralGoogle now auto-expands AI answers, pushing links down Browse all stories →